A PHASE I/II STUDY OF VORINOSTAT PLUS DAILY TEMOZOLOMIDE AND BEVACIZUMAB IN THE TREATMENT OF PATIENTS WITH RECURRENT MALIGNANT GLIOMA
Publication
, Conference
Reardon, DA; Vredenburgh, JJ; Desjardins, A; Janney, DE; Peters, K; Sampson, J; Gururangan, S; Friedman, HS
Published in: NEURO-ONCOLOGY
November 1, 2010
Duke Scholars
Published In
NEURO-ONCOLOGY
ISSN
1522-8517
Publication Date
November 1, 2010
Volume
12
Start / End Page
73 / 73
Location
Hollywood, FL
Publisher
OXFORD UNIV PRESS INC
Conference Name
Advances in Inflammatory Bowel Diseases Crohns and Colitis Foundations National Clinical and Research Conference
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Reardon, D. A., Vredenburgh, J. J., Desjardins, A., Janney, D. E., Peters, K., Sampson, J., … Friedman, H. S. (2010). A PHASE I/II STUDY OF VORINOSTAT PLUS DAILY TEMOZOLOMIDE AND BEVACIZUMAB IN THE TREATMENT OF PATIENTS WITH RECURRENT MALIGNANT GLIOMA. In NEURO-ONCOLOGY (Vol. 12, pp. 73–73). Hollywood, FL: OXFORD UNIV PRESS INC.
Reardon, David A., James J. Vredenburgh, Annick Desjardins, Dorothea E. Janney, Katherine Peters, John Sampson, Sri Gururangan, and Henry S. Friedman. “A PHASE I/II STUDY OF VORINOSTAT PLUS DAILY TEMOZOLOMIDE AND BEVACIZUMAB IN THE TREATMENT OF PATIENTS WITH RECURRENT MALIGNANT GLIOMA.” In NEURO-ONCOLOGY, 12:73–73. OXFORD UNIV PRESS INC, 2010.
Reardon DA, Vredenburgh JJ, Desjardins A, Janney DE, Peters K, Sampson J, et al. A PHASE I/II STUDY OF VORINOSTAT PLUS DAILY TEMOZOLOMIDE AND BEVACIZUMAB IN THE TREATMENT OF PATIENTS WITH RECURRENT MALIGNANT GLIOMA. In: NEURO-ONCOLOGY. OXFORD UNIV PRESS INC; 2010. p. 73–73.
Reardon, David A., et al. “A PHASE I/II STUDY OF VORINOSTAT PLUS DAILY TEMOZOLOMIDE AND BEVACIZUMAB IN THE TREATMENT OF PATIENTS WITH RECURRENT MALIGNANT GLIOMA.” NEURO-ONCOLOGY, vol. 12, OXFORD UNIV PRESS INC, 2010, pp. 73–73.
Reardon DA, Vredenburgh JJ, Desjardins A, Janney DE, Peters K, Sampson J, Gururangan S, Friedman HS. A PHASE I/II STUDY OF VORINOSTAT PLUS DAILY TEMOZOLOMIDE AND BEVACIZUMAB IN THE TREATMENT OF PATIENTS WITH RECURRENT MALIGNANT GLIOMA. NEURO-ONCOLOGY. OXFORD UNIV PRESS INC; 2010. p. 73–73.
Published In
NEURO-ONCOLOGY
ISSN
1522-8517
Publication Date
November 1, 2010
Volume
12
Start / End Page
73 / 73
Location
Hollywood, FL
Publisher
OXFORD UNIV PRESS INC
Conference Name
Advances in Inflammatory Bowel Diseases Crohns and Colitis Foundations National Clinical and Research Conference
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences